Literature DB >> 12455496

Molecular epidemiology of malaria in Cameroon. XIII. Analysis of pfcrt mutations and in vitro chloroquine resistance.

Leonardo K Basco1.   

Abstract

The key Lys76Thr amino-acid substitution in Plasmodium falciparum chloroquine-resistance transporter (PfCRT) has been shown to be a reliable marker associated with chloroquine-resistant phenotype in reference clones, but few discordant results have been observed in field isolates. To further examine the relationship between in vitro chloroquine response and pfcrt alleles, the entire exon 2 of the pfcrt gene of 157 Cameroonian isolates was sequenced. All isolates were characterized as having either Cys-72, Met-74, Asn-75, and Lys-76 (wild-type alleles), Cys-72, Ile-74, Glu-75, and Thr-76 (mutant alleles), or mixed alleles. The hypothetical threshold 50% inhibitory concentration (IC50) set at 100 nM distinguished between isolates carrying the wild-type alleles and those with mutant alleles in a large majority of cases (135 of 139 isolates with unmixed pfcrt alleles). Isolates presenting discordant results generally had IC50s within an intermediate range. In vitro chloroquine response of isolates with mixed pfcrt alleles was highly variable. Although discordant results between chloroquine-resistant phenotype and pfcrt alleles were not explained by the immediate adjacent codons, the key Lys76Thr codon may prove to be a highly reliable genetic marker for the epidemiologic monitoring of chloroquine resistance by means of molecular techniques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12455496     DOI: 10.4269/ajtmh.2002.67.388

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

Review 1.  PfCRT and its role in antimalarial drug resistance.

Authors:  Andrea Ecker; Adele M Lehane; Jérôme Clain; David A Fidock
Journal:  Trends Parasitol       Date:  2012-09-25

2.  Molecular surveillance of drug-resistant Plasmodium falciparum in two distinct geographical areas of Nigeria.

Authors:  Olusola Ojurongbe; Segun I Oyedeji; Wellington A Oyibo; Adetola F Fagbenro-Beyioku; Jürgen F Kun
Journal:  Wien Klin Wochenschr       Date:  2010-11-12       Impact factor: 1.704

3.  Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.

Authors:  Sandie Menard; Isabelle Morlais; Rachida Tahar; Collins Sayang; Pembe Issamou Mayengue; Xavier Iriart; Françoise Benoit-Vical; Brigitte Lemen; Jean-François Magnaval; Parfait Awono-Ambene; Leonardo K Basco; Antoine Berry
Journal:  Malar J       Date:  2012-04-12       Impact factor: 2.979

4.  Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data.

Authors:  Anne E P Frosch; Meera Venkatesan; Miriam K Laufer
Journal:  Malar J       Date:  2011-05-09       Impact factor: 2.979

5.  Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries.

Authors:  Myriam Gharbi; Jennifer A Flegg; Bruno Pradines; Ako Berenger; Magatte Ndiaye; Abdoulaye A Djimdé; Cally Roper; Véronique Hubert; Eric Kendjo; Meera Venkatesan; Philippe Brasseur; Oumar Gaye; André T Offianan; Louis Penali; Jacques Le Bras; Philippe J Guérin
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

6.  Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon.

Authors:  Nicaise Tuikue Ndam; Leonardo K Basco; Vincent Foumane Ngane; Ahidjo Ayouba; Eitel Mpoudi Ngolle; Philippe Deloron; Martine Peeters; Rachida Tahar
Journal:  Malar J       Date:  2017-03-27       Impact factor: 2.979

7.  Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.

Authors:  Francis Tsombeng Foguim; Hervé Bogreau; Mathieu Gendrot; Joel Mosnier; Isabelle Fonta; Nicolas Benoit; Rémy Amalvict; Marylin Madamet; Sharon Wein; Bruno Pradines
Journal:  Malar J       Date:  2020-06-05       Impact factor: 2.979

8.  Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998-2020).

Authors:  Peter Thelma Ngwa Niba; Akindeh M Nji; Marie-Solange Evehe; Innocent M Ali; Palmer Masumbe Netongo; Randolph Ngwafor; Marcel N Moyeh; Lesley Ngum Ngum; Oliva Ebie Ndum; Fon Abongwa Acho; Cyrille Mbanwi Mbu'u; Dorothy A Fosah; Barbara Atogho-Tiedeu; Olivia Achonduh-Atijegbe; Rosine Djokam-Dadjeu; Jean Paul Kengne Chedjou; Jude D Bigoga; Carole Else Eboumbou Moukoko; Anthony Ajua; Eric Achidi; Esther Tallah; Rose G F Leke; Alexis Tourgordi; Pascal Ringwald; Michael Alifrangis; Wilfred F Mbacham
Journal:  Malar J       Date:  2021-01-09       Impact factor: 2.979

9.  Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study.

Authors:  Tobias O Apinjoh; Regina N Mugri; Olivo Miotto; Hanesh F Chi; Rolland B Tata; Judith K Anchang-Kimbi; Eleanor M Fon; Delphine A Tangoh; Robert V Nyingchu; Christopher Jacob; Roberto Amato; Abdoulaye Djimde; Dominic Kwiatkowski; Eric A Achidi; Alfred Amambua-Ngwa
Journal:  Infect Dis Poverty       Date:  2017-11-06       Impact factor: 4.520

Review 10.  Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination.

Authors:  Christophe Antonio-Nkondjio; Cyrille Ndo; Flobert Njiokou; Jude D Bigoga; Parfait Awono-Ambene; Josiane Etang; Albert Same Ekobo; Charles S Wondji
Journal:  Parasit Vectors       Date:  2019-10-26       Impact factor: 4.047

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.